Gyre Therapeutics (NASDAQ:GYRE) Trading Up 8.2%

Gyre Therapeutics, Inc. (NASDAQ:GYRE) shares traded up 8.2% on Monday . The company traded as high as $11.82 and last traded at $11.78. 19,577 shares traded hands during mid-day trading, a decline of 74% from the average session volume of 74,201 shares. The stock had previously closed at $10.89.

Gyre Therapeutics Stock Up 2.0 %

The business’s 50 day moving average price is $12.19 and its two-hundred day moving average price is $14.37.

Insider Activity

In other news, Director Nassim Usman sold 3,452 shares of the firm’s stock in a transaction that occurred on Friday, June 28th. The shares were sold at an average price of $12.00, for a total value of $41,424.00. Following the sale, the director now directly owns 1,636 shares in the company, valued at approximately $19,632. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 2.92% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Gyre Therapeutics

Hedge funds have recently added to or reduced their stakes in the business. Rhumbline Advisers acquired a new stake in Gyre Therapeutics during the 2nd quarter worth approximately $123,000. Renaissance Technologies LLC acquired a new stake in Gyre Therapeutics during the 2nd quarter worth approximately $166,000. Bank of New York Mellon Corp acquired a new stake in Gyre Therapeutics during the 2nd quarter worth approximately $218,000. Finally, WINTON GROUP Ltd acquired a new stake in Gyre Therapeutics during the 2nd quarter worth approximately $220,000. 23.99% of the stock is currently owned by institutional investors and hedge funds.

About Gyre Therapeutics

Gyre Therapeutics, Inc, a biopharmaceutical company, primarily focuses on the development and commercialization of Hydronidone for the treatment of Metabolic Dysfunction Associated Steatohepatitis in the United States. Its Hydronidone is also being evaluated for the treatment of liver fibrosis across a spectrum of chronic liver diseases.